Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

GRAFTYS BCP

K-Number: K073064 · 2008-03-11

ApplicantGraftys
Decision Date2008-03-11
Product CodeMQV
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

GRAFTYS BCP is the device name listed in this FDA 510(k) record. The listed applicant is Graftys. It received FDA 510(k) clearance on 2008-03-11 under 510(k) number K073064. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GRAFTYS BCP?

GRAFTYS BCP is a medical device that received FDA 510(k) clearance on 2008-03-11. The listed applicant is Graftys. The 510(k) number is K073064.

When did GRAFTYS BCP receive FDA 510(k) clearance?

GRAFTYS BCP received FDA 510(k) clearance on 2008-03-11, under 510(k) number K073064.

Who is the listed applicant for GRAFTYS BCP?

The FDA 510(k) record lists Graftys as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for GRAFTYS BCP?

The FDA product code for GRAFTYS BCP is MQV.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Graftys as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: MQV)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑